Anavex Life Sciences Corp (AVXL)

[Jonjones325]

The gene pathway poster stated, “These findings will facilitate contextualization of upcoming readout of ANAVEX®2-73 Phase 2b/3 Alzheimer’s disease clinical trial”

“Expression levels of dysregulated neurodegenerative genes were restored by the therapeutic effect of ANAVEX®2-73”

That poster was published July 31st.

I’m guessing at that time they likely had an idea if the Alz trial was successful. Or by looking at the mounds of OLE Alz data from our 2B/3.

Everything the the company has ever said and presented has pointed to the same conclusion. Every piece of 3rd party data has confirmed it as well. Hundreds of patients in the OLEs are also likely adding to their confidence.

Hence no change in language. With the exception of a decrease in qualifiers.